南模生物
(688265)
| 流通市值：30.14亿 | | | 总市值：30.14亿 |
| 流通股本：7796.35万 | | | 总股本：7796.35万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 99,917,106.36 | 421,024,337.24 | 302,700,815.36 | 195,763,143.74 |
| 营业收入 | 99,917,106.36 | 421,024,337.24 | 302,700,815.36 | 195,763,143.74 |
| 二、营业总成本 | 101,847,429.13 | 406,371,770.42 | 285,426,118.09 | 183,919,911.5 |
| 营业成本 | 46,005,201.14 | 203,399,567.65 | 142,671,588.01 | 93,757,494.7 |
| 税金及附加 | 703,486.02 | 2,703,374.2 | 1,813,578.59 | 1,322,972.21 |
| 销售费用 | 16,680,650.36 | 60,519,398.9 | 42,999,153.23 | 29,477,290.08 |
| 管理费用 | 16,360,772.16 | 51,017,223.96 | 33,771,016.94 | 16,607,278.94 |
| 研发费用 | 20,461,429.8 | 86,688,501.84 | 62,717,010.22 | 41,588,634.82 |
| 财务费用 | 1,635,889.65 | 2,043,703.87 | 1,453,771.1 | 1,166,240.75 |
| 其中:利息费用 | 556,554.21 | 2,415,789.51 | 1,857,809.49 | 1,390,821.72 |
| 其中:利息收入 | 638,286.43 | 2,576,854.68 | 2,084,904.07 | -1,313,862.02 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 3,734,189.83 | 17,682,289.12 | 12,582,196.26 | 8,610,993.1 |
| 加:投资收益 | 501,606.26 | 1,775,193.98 | 1,475,730.98 | 1,181,013.5 |
| 资产处置收益 | - | 38,969.27 | 38,969.27 | - |
| 资产减值损失(新) | -2,025,965.64 | -2,099,198.48 | -1,604,289.04 | -1,712,063.32 |
| 信用减值损失(新) | -2,337,183.8 | -10,163,116.15 | -9,296,325.18 | -6,971,157.24 |
| 其他收益 | 2,511,455.7 | 8,101,370.69 | 6,084,852.09 | 4,721,030.86 |
| 四、营业利润 | 453,779.58 | 29,988,075.25 | 26,555,831.65 | 17,673,049.14 |
| 加:营业外收入 | - | 356.07 | 356.04 | 356.04 |
| 减:营业外支出 | 57,869 | 887,300.77 | 831,398.75 | 98,599.2 |
| 五、利润总额 | 395,910.58 | 29,101,130.55 | 25,724,788.94 | 17,574,805.98 |
| 减:所得税费用 | -287,724.98 | -2,335,399.21 | -1,040,116.17 | -592,569.02 |
| 六、净利润 | 683,635.56 | 31,436,529.76 | 26,764,905.11 | 18,167,375 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 683,635.56 | 31,436,529.76 | 26,764,905.11 | 18,167,375 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 683,635.56 | 31,436,529.76 | 26,764,905.11 | 18,167,375 |
| 扣除非经常损益后的净利润 | -5,004,375.58 | 8,731,594.17 | 10,277,886.16 | 5,914,262.8 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.01 | 0.42 | 0.34 | 0.23 |
| (二)稀释每股收益 | 0.01 | 0.42 | 0.34 | 0.23 |
| 八、其他综合收益 | 17,200.94 | -277,676.1 | -155,144.81 | -62,914.59 |
| 归属于母公司股东的其他综合收益 | 17,200.94 | -277,676.1 | -155,144.81 | -62,914.59 |
| 九、综合收益总额 | 700,836.5 | 31,158,853.66 | 26,609,760.3 | 18,104,460.41 |
| 归属于母公司股东的综合收益总额 | 700,836.5 | 31,158,853.66 | 26,609,760.3 | 18,104,460.41 |
| 公告日期 | 2026-04-30 | 2026-04-27 | 2025-10-30 | 2025-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |